NCT00004061
- Conditions
- Blast Crisis, Bone Marrow Diseases, Burkitt Lymphoma, +42 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Clinical trial condition
Leukemia, Myeloid, Chronic-Phase
Explore clinical trials studying Leukemia, Myeloid, Chronic-Phase. Study availability and eligibility vary by location and protocol.
314 public trials
21 recruiting studies
Leukemia, Myeloid, Chronic-Phase trial results
NCT00003395
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +70 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00004052
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
- University of Texas - MD Anderson Cancer Center Houston, Texas, United States
Completed
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
NCT00004065
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +110 more
- Locations
-
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
Completed
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia
NCT00005618
- Conditions
- Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +16 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00005634
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +65 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Completed
Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy
NCT00066599
- Conditions
- Agranulocytosis, Blast Crisis, Blood Protein Disorders, +89 more
- Locations
-
- Children's Hospital of Orange County Orange, California, United States
- Children's Hospital and Health Center, San Diego San Diego, California, United States
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
- Duke Comprehensive Cancer Center Durham, North Carolina, United States
Completed
Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
NCT00045422
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00042900
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +90 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00003694
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +13 more
- Locations
-
- Dana-Farber Harvard Cancer Center Boston, Massachusetts, United States